Thionucleoside derivative or salt thereof, and pharmaceutical composition
US10059734B2 · kind B2 · utility
4Cited by
16References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 28, 2017 |
| Grant date | Aug 28, 2018 |
| Priority date | — |
| Expiry date | Apr 28, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are a compound and a pharmaceutical composition that exhibit an excellent drug efficacy against a tumor, in particular a tumor which has acquired resistance to gemcitabine. Specifically, provided is a thionucleoside derivative represented by General Formula [1]
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.